Georgina Pope

HotHouse Therapeutics is rewriting the future of drug discovery with BotanAI and BotanBio - our AI and plant bioengineering platforms that design and make molecules labs can’t reach. By transforming plants into sustainable biofactories, we unlock vast new chemical space, creating next-generation vaccine adjuvants and breakthrough therapeutics in days, not years. The urgency is clear: 62% of today’s medicines are natural or nature-inspired, yet conventional chemistry is slow, expensive, and environmentally harmful. As a sustainable biotech, our approach is different. Because our medicines grow in plants, they scale through vertical farming, are carbon-positive by design, and avoid destructive extraction. With deep expertise in plant science, chemistry, and AI, we’re building not just a pipeline, but a platform - delivering next-generation medicines that are greener, faster, and smarter.

Developing antibacterials through an adaptable DNA-based platform to counter the clinical challenge of the rise of drug-resistant bacterial strains.

Developing antibacterials through an adaptable DNA-based platform to counter the clinical challenge of the rise of drug-resistant bacterial strains.

NatureMetrics is a world leader in delivering nature data and intelligence, deploying cutting-edge technology to generate biodiversity insights at scale using environmental DNA (eDNA), Earth Observation (EO) and advanced data science and AI. Our Nature Intelligence Platform is transforming how businesses report their nature impact, bringing a scalable solution to biodiversity monitoring, equipping global businesses for new nature reporting commitments. Driving impact for over 500 clients across 100+ countries, weve recently been recognised as a Bloomberg Top 25 UK Startup to Watch, a Bloomberg NEF Finalist 2024 and nominated for the Google Geo for Good Impact Awards.

HotHouse Therapeutics is rewriting the future of drug discovery with BotanAI and BotanBio - our AI and plant bioengineering platforms that design and make molecules labs can’t reach. By transforming plants into sustainable biofactories, we unlock vast new chemical space, creating next-generation vaccine adjuvants and breakthrough therapeutics in days, not years. The urgency is clear: 62% of today’s medicines are natural or nature-inspired, yet conventional chemistry is slow, expensive, and environmentally harmful. As a sustainable biotech, our approach is different. Because our medicines grow in plants, they scale through vertical farming, are carbon-positive by design, and avoid destructive extraction. With deep expertise in plant science, chemistry, and AI, we’re building not just a pipeline, but a platform - delivering next-generation medicines that are greener, faster, and smarter.

Developing antibacterials through an adaptable DNA-based platform to counter the clinical challenge of the rise of drug-resistant bacterial strains.

Developing antibacterials through an adaptable DNA-based platform to counter the clinical challenge of the rise of drug-resistant bacterial strains.

NatureMetrics is a world leader in delivering nature data and intelligence, deploying cutting-edge technology to generate biodiversity insights at scale using environmental DNA (eDNA), Earth Observation (EO) and advanced data science and AI. Our Nature Intelligence Platform is transforming how businesses report their nature impact, bringing a scalable solution to biodiversity monitoring, equipping global businesses for new nature reporting commitments. Driving impact for over 500 clients across 100+ countries, weve recently been recognised as a Bloomberg Top 25 UK Startup to Watch, a Bloomberg NEF Finalist 2024 and nominated for the Google Geo for Good Impact Awards.